IBDEI1ES ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25260,0)
 ;;=785.4^^145^1537^35
 ;;^UTILITY(U,$J,358.3,25260,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25260,1,4,0)
 ;;=4^785.4
 ;;^UTILITY(U,$J,358.3,25260,1,5,0)
 ;;=5^Gangrene
 ;;^UTILITY(U,$J,358.3,25260,2)
 ;;=^49194
 ;;^UTILITY(U,$J,358.3,25261,0)
 ;;=704.9^^145^1537^36
 ;;^UTILITY(U,$J,358.3,25261,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25261,1,4,0)
 ;;=4^704.9
 ;;^UTILITY(U,$J,358.3,25261,1,5,0)
 ;;=5^Hair Desease NOS
 ;;^UTILITY(U,$J,358.3,25261,2)
 ;;=^53658
 ;;^UTILITY(U,$J,358.3,25262,0)
 ;;=705.83^^145^1537^37
 ;;^UTILITY(U,$J,358.3,25262,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25262,1,4,0)
 ;;=4^705.83
 ;;^UTILITY(U,$J,358.3,25262,1,5,0)
 ;;=5^Hidradenitis
 ;;^UTILITY(U,$J,358.3,25262,2)
 ;;=^184621
 ;;^UTILITY(U,$J,358.3,25263,0)
 ;;=703.8^^145^1537^41
 ;;^UTILITY(U,$J,358.3,25263,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25263,1,4,0)
 ;;=4^703.8
 ;;^UTILITY(U,$J,358.3,25263,1,5,0)
 ;;=5^Onychodystrphy/Gryphosis/Lysis
 ;;^UTILITY(U,$J,358.3,25263,2)
 ;;=^271926
 ;;^UTILITY(U,$J,358.3,25264,0)
 ;;=695.89^^145^1537^38
 ;;^UTILITY(U,$J,358.3,25264,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25264,1,4,0)
 ;;=4^695.89
 ;;^UTILITY(U,$J,358.3,25264,1,5,0)
 ;;=5^Intertrigo
 ;;^UTILITY(U,$J,358.3,25264,2)
 ;;=^88044
 ;;^UTILITY(U,$J,358.3,25265,0)
 ;;=214.9^^145^1537^39
 ;;^UTILITY(U,$J,358.3,25265,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25265,1,4,0)
 ;;=4^214.9
 ;;^UTILITY(U,$J,358.3,25265,1,5,0)
 ;;=5^Lipoma NOS
 ;;^UTILITY(U,$J,358.3,25265,2)
 ;;=^71155
 ;;^UTILITY(U,$J,358.3,25266,0)
 ;;=703.0^^145^1537^40
 ;;^UTILITY(U,$J,358.3,25266,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25266,1,4,0)
 ;;=4^703.0
 ;;^UTILITY(U,$J,358.3,25266,1,5,0)
 ;;=5^Onychocryptosis
 ;;^UTILITY(U,$J,358.3,25266,2)
 ;;=^81221
 ;;^UTILITY(U,$J,358.3,25267,0)
 ;;=528.2^^145^1537^43
 ;;^UTILITY(U,$J,358.3,25267,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25267,1,4,0)
 ;;=4^528.2
 ;;^UTILITY(U,$J,358.3,25267,1,5,0)
 ;;=5^Oral Aphthae
 ;;^UTILITY(U,$J,358.3,25267,2)
 ;;=^114480
 ;;^UTILITY(U,$J,358.3,25268,0)
 ;;=692.72^^145^1537^44
 ;;^UTILITY(U,$J,358.3,25268,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25268,1,4,0)
 ;;=4^692.72
 ;;^UTILITY(U,$J,358.3,25268,1,5,0)
 ;;=5^Photosensitivity
 ;;^UTILITY(U,$J,358.3,25268,2)
 ;;=^93951
 ;;^UTILITY(U,$J,358.3,25269,0)
 ;;=692.6^^145^1537^46
 ;;^UTILITY(U,$J,358.3,25269,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25269,1,4,0)
 ;;=4^692.6
 ;;^UTILITY(U,$J,358.3,25269,1,5,0)
 ;;=5^Poison Ivy
 ;;^UTILITY(U,$J,358.3,25269,2)
 ;;=^271908
 ;;^UTILITY(U,$J,358.3,25270,0)
 ;;=698.0^^145^1537^62
 ;;^UTILITY(U,$J,358.3,25270,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25270,1,4,0)
 ;;=4^698.0
 ;;^UTILITY(U,$J,358.3,25270,1,5,0)
 ;;=5^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,25270,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,25271,0)
 ;;=698.9^^145^1537^61
 ;;^UTILITY(U,$J,358.3,25271,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25271,1,4,0)
 ;;=4^698.9
 ;;^UTILITY(U,$J,358.3,25271,1,5,0)
 ;;=5^Pruritic Disorder,Unsp
 ;;^UTILITY(U,$J,358.3,25271,2)
 ;;=^123977
 ;;^UTILITY(U,$J,358.3,25272,0)
 ;;=696.1^^145^1537^63
 ;;^UTILITY(U,$J,358.3,25272,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25272,1,4,0)
 ;;=4^696.1
 ;;^UTILITY(U,$J,358.3,25272,1,5,0)
 ;;=5^Psoriasis
 ;;^UTILITY(U,$J,358.3,25272,2)
 ;;=^87816
 ;;^UTILITY(U,$J,358.3,25273,0)
 ;;=287.0^^145^1537^64
 ;;^UTILITY(U,$J,358.3,25273,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25273,1,4,0)
 ;;=4^287.0
 ;;^UTILITY(U,$J,358.3,25273,1,5,0)
 ;;=5^Purpura, Vascular
 ;;^UTILITY(U,$J,358.3,25273,2)
 ;;=^101365
